Fatigue Formula
NDC 83027-0125, Medulla Ossis Suis, Spleen (Bovine), Thymus (Ovine), Carcinosin, Cytomegalovirus Nosode, Influenzinum (2022-2023), Streptococcus Viridans, Toxoplasma Gondii, Epstein-Bar Virus Nosode, spray, from Nutritional Specialties, Inc..
- Product NDC
- 83027-0125
- Status
- Listed
- Labeler
- Nutritional Specialties, Inc.
- Dosage form
- SPRAY
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83027-0125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SUS SCROFA BONE MARROW6 [hp_X]/mL
- BOS TAURUS SPLEEN6 [hp_X]/mL
- LAMB6 [hp_X]/mL
- HUMAN BREAST TUMOR CELL16 [hp_X]/mL
- HUMAN HERPESVIRUS 516 [hp_X]/mL
- INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)16 [hp_X]/mL
- INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)16 [hp_X]/mL
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)16 [hp_X]/mL
- INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)16 [hp_X]/mL
- STREPTOCOCCUS VIRIDANS GROUP16 [hp_X]/mL
- TOXOPLASMA GONDII16 [hp_X]/mL
- HUMAN HERPESVIRUS 416 [hp_C]/mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Meat Proteins [EXT]; Non-Standardized Food Allergenic Extract [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83027-0125-1 | 83027012501 | 60 mL in 1 BOTTLE, SPRAY (83027-0125-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 83027-0125 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83027-0125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83027-0125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.